---
title: "Tolrestat - Diabetic complication"
sidebar: mydoc_sidebar
permalink: db02383-mesh-d048909-1.html
toc: false 
---


Path ID: `DB02383_MESH_D048909_1`
{% include image.html url="images/db02383-mesh-d048909-1.png" file="db02383-mesh-d048909-1.png" alt="db02383-mesh-d048909-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C040550 | Tolrestat | Drug |
| UniProt:P15121 | Aldose reductase | Protein |
| MESH:D013012 | Sorbitol | ChemicalSubstance |
| GO:0006970 | Response to osmotic stress | BiologicalProcess |
| HP:0000518 | Cataract | PhenotypicFeature |
| MESH:D048909 | Diabetic complication | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tolrestat | DECREASES ACTIVITY OF | Aldose Reductase |
| Aldose Reductase | INCREASES ABUNDANCE OF | Sorbitol |
| Sorbitol | CAUSES | Response To Osmotic Stress |
| Response To Osmotic Stress | POSITIVELY CORRELATED WITH | Cataract |
| Cataract | MANIFESTATION OF | Diabetic Complication |
|---------|-----------|---------|

Comment: Withdrawn

Reference: [https://go.drugbank.com/drugs/DB02383#mechanism-of-action](https://go.drugbank.com/drugs/DB02383#mechanism-of-action){:target="_blank"}